Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
AQP4-dependent enhancement of glymphatic function attenuates tau pathology and neurodegeneration in PS19 mice
AuthorsKaoru Yamada; Kazuhisa Ishida; Asami Sakamoto; Hitoshi Shimada; Masaki Watanabe; Masato Shimojo; Hironaka Igarashi; Takeshi Iwatsubo
Affiliations1. Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; 2. Dementia Inclusion and Therapeutics, Graduate School of Medicine, The University of Tokyo Hospital, Tokyo, Japan; 3. Center for Integrated Human Brain Science, Brain Research Institute, Niigata University, Niigata, Japan; 4. Neuroscience Drug Discovery Unit, Takeda Pharmaceutical Co., Ltd. Osaka, Research, Japan; 5. National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan
Passive amyloid-β immunotherapy in Alzheimer’s disease: a multicellular clearance system beyond plaque removal
AuthorsXiaoni Zhan; Chenchen Liu; Changjiang Yu; Nils Lindblom; Tomas Deierborg; Asgeir Kobro-Flatmoen; Gunnar K. Gouras; Gehua Wen
Affiliations1. School of Forensic Medicine, China Medical University, Shenyang, China; 2. Neural Plasticity and Repair Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden; 3. Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 4. Department of Neurology, The Fourth Affiliated Hospital of China Medical University, Shenyang, China; 5. Experimental Dementia Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden; 6. Experimental Neuroinflammation Lab, Department of Experimental Medical Science, Lund University, Lund, Sweden; 7. Kavli Institute for Systems Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway; 8. Norwegian Health Association Centre for Dementia Research, Norwegian University of Science and Technology (NTNU), Postbox, Trondheim, Norway
Breaking the glial loop: astrocytic PAD2 and citrullinated vimentin drive microglial dysfunction in Alzheimer’s disease
AuthorsJeff Y. L. Lam; Guojun Bu
Affiliations1. Division of Life Science and State Key Laboratory of Nervous System Disorders, The Hong Kong University of Science and Technology, Hong Kong, China
A reappraisal of APOE genetic effects on Alzheimer’s disease risk in the Japanese population: a meta-analysis
AuthorsAkinori Miyashita; Norikazu Hara; Ai Obinata; Tamao Tsukie; Mai Hasegawa; Takanobu Ishiguro; Kensaku Kasuga; Masataka Kikuchi; Tadafumi Hashimoto; Takahisa Kanekiyo; Takeshi Ikeuchi
Affiliations1. Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan; 2. Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan; 3. Department of Diagnostic Innovation Science, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan; 4. Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan; 5. Department of Neuroscience, Mayo Clinic, Jacksonville, USA
RAN translation as a dominant pathogenic axis in C9ORF72-associated ALS and FTD models
AuthorsPegah Masrori; Defne Audrey Amado
Affiliations1. Department of Neurology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; 2. Institute of Neuroscience, UCLouvain, Brussels, Belgium; 3. Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA; 4. Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children’s Hospital of Philadelphia, Philadelphia, USA
Tau extent outperforms tau load as a predictor of neurodegeneration in Alzheimer’s disease
AuthorsArthur C. Macedo; Lydia Trudel; Seyyed Ali Hosseini; Joseph Therriault; Étienne Aumont; Gleb Bezgin; Nesrine Rahmouni; Jenna Stevenson; Cécile Tissot; Marcel S. Woo; Stijn Servaes; Stuart Mitchell; Jaime Fernandez-Arias; Brandon Hall; Tevy Chan; Marina Pereira Gonçalves; Pamela C. L. Ferreira; João Pedro Ferrari-Souza; Bruna Bellaver; Firoza Z. Lussier; Andréa L. Benedet; Nicholas J. Ashton; Henrik Zetterberg; Kaj Blennow; Dana L. Tudorascu; Eduardo R. Zimmer; Maxime Montembeault; Jean-Paul Soucy; Jesse Klostranec; Tharick A. Pascoal; Paolo Vitali; Pedro Rosa-Neto
Affiliations1. Translational Neuroimaging Laboratory, The McGill University Research Centre for Studies in Aging, McConnell Brain Imaging Centre (BIC), Montreal Neurological Institute, Montréal, Canada; 2. Department of Neurology and Neurosurgery, McGill University, Québec, Canada; 3. Montreal Neurological Institute, Québec, Canada; 4. Lawrence Berkeley National Laboratory, Berkeley, USA; 5. Translational Neurodegeneration Laboratory, Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 6. Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, USA; 7. Graduate Program in Biological Sciences: Pharmacology and Therapeutics; and Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; 8. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; 9. Wallenberg Centre for Molecular Medicine, University of Gothenburg, Gothenburg, Sweden; 10. King’s College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute, London, UK; 11. NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, UK; 12. Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; 13. Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK; 14. UK Dementia Research Institute at UCL, London, UK; 15. Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China; 16. Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA; 17. Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France; 18. Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, P.R. China; 19. Brain Institute of Rio Grande do Sul, Porto Alegre, Brazil; 20. Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, USA; 21. The Peter O’Donnell Jr. Brain Institute (OBI), University of Texas Southwestern Medical Centre (UTSW), Dallas, USA
Insulin resistance alters cortical inhibitory neurons and microglia to exacerbate Alzheimer’s knock-in mouse phenotypes
AuthorsLaShae Nicholson; Si Jie Tang; Tejaswini Karra; Habiba Abouelatta; Stephen M. Strittmatter
Affiliations1. Departments of Neuroscience and Neurology, Yale School of Medicine, New Haven, USA; 2. Program in Cellular Neuroscience, Neurodegeneration, and Repair, Yale School of Medicine, New Haven, USA; 3. School of Medicine, University of California Davis Medical Center, Sacramento, USA; 4. Institute of Neuropathology, University Medical Centre Göttingen, Göttingen, Germany; 5. Department of Neuroscience and Behavior, Mount Holyoke College, South Hadley, USA
3’UTR regulation of axon translation and optic nerve regeneration
AuthorsMinjuan Bian; Emma L. Huie; Xin Xia; Michael Nahmou; Savana A. Maxfield; Liang Li; Liang Liu; Ziming Luo; Christina Tsien; Katherine J. Healzer; Heather V. Chang; Kristina Russano; Jeffrey L. Goldberg
Affiliations1. Department of Ophthalmology, Mary M. and Sash A. Spencer Center for Vision Research, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, USA
Cholesterol metabolism in neurodegenerative diseases: mechanisms and therapeutic advances
AuthorsDezhen Tu; Yuxiao Zheng; Pingping Ding; Miao Shen; Wangyang Tang; Bin Wei; Hongyan Wang
Affiliations1. Innovative Institute of Tumor Immunity and Medicine, Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, The First Affiliated Hospital of Anhui Medical University, Hefei, China; 2. State Key Laboratory of Cell Biology & Key Laboratory of RNA Science and Engineering, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China; 3. Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China; 4. Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China
Temporal single-cell atlas of full-length Huntington’s disease mouse model defines stage-specific signatures of corticostriatal dysfunction
AuthorsAshley B. Robbins; Paul T. Ranum; Icnelia Huerta-Ocampo; Michael Kuckyr; Beverly L. Davidson
Affiliations1. Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children’s Hospital of Philadelphia, Philadelphia, USA; 2. Neuroscience Graduate Group, Biomedical Graduate Studies Program, University of Pennsylvania, Philadelphia, USA; 3. Latus Bio, Philadelphia, USA; 4. Cell and Molecular Biology Graduate Group, Biomedical Graduate Studies Program, University of Pennsylvania, Philadelphia, USA; 5. Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, USA
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
